BNIP3 has also been applied in a RiskScore model of cholangiocarcinoma, expressing significantly lower in cholangiocarcinoma than normal tissues but higher expression is related to poorer prognosis (Wang Z. et al., 2022), as in BC. The gene discussed is BNIP3; the disease is breast cancer.